Onelife Nutriscience
A consumer healthcare brands company.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Early VC | ||
| Total Funding | 000k | ||
Related Content
Onelife Nutriscience Private Limited operates as a direct-to-consumer (D2C) and business-to-consumer (B2C) entity in the nutraceuticals sector, providing dietary nutritional supplements for a variety of health needs. The company was founded in 2019 by Gaurav Aggarwal, who serves as the CEO. Aggarwal brings over two decades of experience in the nutrition and pharmaceutical industries to the venture and is also a Director at Lasons India Pvt Ltd, a global pharmaceutical manufacturer. His background in a family involved in producing Vitamin B3 on a global scale provided the foundation for establishing a B2C healthcare brand.
The Mumbai-based company targets health-conscious consumers with a product portfolio of over 100 items spanning wellness, nutrition, beauty, and sports nutrition. These offerings include vitamins, herbal supplements, micronutrients, antioxidants, superfoods, and protein powders designed for needs such as weight management, muscle building, and overall wellness. The products are formulated based on scientific research and manufactured in ISO, GMP, and HACCP certified facilities. Onelife also produces Vitamin B3 (Niacin and Niacinamide) and specialty chemicals, with exports reaching over 100 countries.
The company's business strategy involves both online and offline expansion. Its products are available through its e-commerce website and have a physical presence in more than 15 cities across West and North India. Onelife has secured funding to facilitate this growth, including a pre-Series A round of Rs 5 crore from high-net-worth individuals and subsequent undisclosed amounts from Lasons India and Wipro Consumer Care Ventures. These funds are earmarked for geographical expansion, marketing, and team building. As of March 2023, the company reported an annual revenue of ₹4.98Cr and has received total funding of $3.65M over three rounds, with a post-money valuation of $5.78M as of September 2023.
Keywords: nutritional supplements, dietary supplements, health and wellness, nutraceuticals, vitamin B3, sports nutrition, D2C healthcare, beauty supplements, herbal supplements, Gaurav Aggarwal, preventive healthcare, Indian nutraceutical market, superfoods, immunity boosters, weight management, muscle building, protein powders, e-commerce health, wellness products, Onelife